A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
CompletedNCT02571816
Astellas Pharma Global Development, Inc.Healthy, Hepatic Impairment
Start: 2015-10-23End: 2016-03-05Updated: 2024-11-05